QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS

摘要

This invention provides quinazoline analogs of Formula (I): where A is bonde d to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to two independent R3 groups. The invention also includes methods of using compounds of Formula (I) as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.